Clinical Trials Logo

Filter by:
NCT ID: NCT05359640 Completed - Lower Back Pain Clinical Trials

Invasive Treatment of Lower Back Pain

Start date: April 15, 2022
Phase:
Study type: Observational

Lower back pain, especially chronic, is a very complex condition that has different causes. There is no single pathophysiological mechanism that could explain the causes of low back pain. It is defined as non-specific and results in only symptomatic treatment. The mechanisms of pain overlap and combine with genetic, epigenetic, individual factors and lifestyle. On the other hand, when low back pain has a defined cause, the treatment can be causal. At the beginning of the treatment of patients with non-specific low back pain, identification of those that would probably need more complex treatment is tried. More complex patients, are also referred to physiotherapy, and those who are more likely to develop chronic back pain, should be also referred to a psychologist. An important place, to interrupt the back pain cycle has spine blockades, either local, trigger points blockades, or x-ray-guided blockades of facet joints or nerve roots.

NCT ID: NCT05351918 Completed - Migraine Clinical Trials

Comparison of Two Different Migraine Acupuncture Treatment

Start date: February 1, 2022
Phase:
Study type: Observational

Headache is one of the most common clinical problems. Conventional drug therapy is more successful when complementary and integrative medicine approaches are combined to conventional treatment, as traditional Chinese medicine (TKM). The success of acupuncture therapy depends on the selection of acupuncture points according to TKM pathological mechanisms. Correct selection of points are needed to treat migraine headaches.Acupuncture reduces the consumption of analgesics. In this prospective, randomised study we will compered two methods of acupuncture stimulation: in the control group, all patients will receive the same local points, commonly used to treat migraine in our department, in the study group, local points will be selected according to the site of the headache.

NCT ID: NCT05339308 Completed - Magnesium Clinical Trials

Effects of Magnesium Oil Application on the Muscle Contractile Properties

MG-MCP2022
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties.

NCT ID: NCT05333315 Completed - Hypertension Clinical Trials

Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults

FOODSU
Start date: April 20, 2022
Phase: N/A
Study type: Interventional

In recent years, dietary supplement are of great interest for the improvement of human health. This study is designed as a parallel, randomized, double blind study exploring the efficacy of two months daily oral dosing of five different food supplements together with diet restriction in 120 otherwise healthy overweight or obese adults on different biochemical and anthropometric parameters.

NCT ID: NCT05272228 Completed - Clinical trials for Coenzyme Q Deficiency

Comparative Single-dose Bioavailability Clinical Study of Different Coenzyme Q10 Products

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The randomized, open-label, three period crossover single-dose bioavailability study with three coenzyme Q10 products

NCT ID: NCT05219344 Completed - Clinical trials for Physical Performance

Tissue Flossing and Lower Limb Neuromuscular Function

MF2-TMG-CMJ
Start date: May 20, 2021
Phase: N/A
Study type: Interventional

There is no study investigating different volumes, that is various sets of the configuration of tissue flossing on neuromuscular function. Previously, investigators found that 3 sets of TF impaired neuromuscular function assessed with TMG. Therefore, the aim is to compare the effects of one and two sets of TS on countermovement jump (CMJ) performance and muscle contractile properties.

NCT ID: NCT05218798 Completed - Physical Fitness Clinical Trials

Enhancement of Physical and Combat Preparedness of SAF Members - Validation Study

EPCPSAF-2021
Start date: February 14, 2022
Phase: N/A
Study type: Interventional

The aim of the proposed project is to investigate the reliability, validity, and usefulness of the 30-15 intermittent fitness test in the Slovenian Armed Forces. We will compare the results obtained from a continuous treadmill running test, 2-mile run test, and 30-15IFT.

NCT ID: NCT05216146 Completed - Physical Fitness Clinical Trials

Enhancement of Physical and Combat Preparedness of SAF Members

EPCPSAF-2021
Start date: November 17, 2022
Phase: N/A
Study type: Interventional

Regular and optimal fitness training has a positive effect on reducing risk or injury in addition to enhancing psychophysical and combat skills. On the other hand, excessive fitness training is one of the risk factors for injuries in soldiers. For this reason, it is necessary to establish a new system of the training process and regular monitoring of physical and combat readiness of the SAF with the help of scientific and professional methodology. The proposed research project will run for two years. The main goal of the project is to enhance physical and combat readiness and determine the epidemiology of injuries of members of the Slovenian Armed Forces (SAF). Within this aim, we will also run a validation study aimed to improve existing testing batteries for armed forces.

NCT ID: NCT05198453 Completed - COVID-19 Clinical Trials

Impact of Vaccination in Acute COVID-19

Start date: August 16, 2021
Phase:
Study type: Observational

The aim of this study was to evaluate the association between vaccination with one of the four SARS-CoV-2 vaccines authorized for use in the European Union-BNT162b2, ChAdOx-1S, mRNA-1273 or Ad.26.COV2.S-and progression to critically severe disease among adult patients with PCR-confirmed acute COVID-19.

NCT ID: NCT05191290 Completed - Anticoagulation Clinical Trials

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

Start date: January 21, 2022
Phase: Phase 4
Study type: Interventional

Membrane plasmapheresis is one of the methods for treating immune diseases. Plasmapheresis removes autoantibodies and immune complexes, paraproteins, lipoproteins and reduces the concentration of cytokines. In membrane plasmapheresis, plasma is separated from blood cells by a highly permeable membrane. The filtered plasma is then discarded and replaced with replacement fluid. During the procedure, there is an activation of the coagulation system, because of the extracorporeal blood circulation. The anticoagulation during the procedure is therefore necessary.